IL18 and ischemic stroke: In the current study, we discovered that IPC could significantly inhibit the expression of NLRP3 inflammasome components and partially reduce the level of IL-1β and IL-18 at 6 h and 24 h following ischemic stroke, especially at the 24 h time point.